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Aim: The aim of the present study was to investigate the dynamics of nitric oxide derivative (NOD) formation in mice with trans-
planted tumors and to analize whether synthetic NO-synthase inhibitors, NO-donors and natural compounds could modulate NOD 
synthesis. Materials and Methods: In the study F1(C57BlxCBA), CBA/Lac, BDF and Balb/c mice were used. Endogenous NOD 
synthesis in mice with transplanted Ehrlich carcinoma (EC) and Lewis lung carcinoma (LLC) was estimated by measuring urine 
nitrates (NA) and nitrites (NI) excretion and their concentration in tumor tissue determined by cadmium-reduction method. Results: 
It is shown that EC development is accompanied by increased endogenous NOD formation whereas LLC growth — by its decrease. 
Total NOD excretion with urine in EC-bearing mice during tumor development was in the range of 1.1x10–7-7.0x10–6 mol/kg body 
weight that was 1.7–6.8 times higher than that in LLC-bearing mice. Treatment of EC-bearing animals with Nώ-nitro-L-arginine 
and aminoguanidine resulted in decreased NOD formation causing moderate tumor growth retardation. Effect of treatment with 
nitroprusside was shown to be dependent on the rout of its administration and dosage. Treatment of EC-bearing mice with picno-
genol, tannic acid, spirulina and paprika enriched with selenium resulted in tumor growth inhibition at the early stage of EC growth 
accompanied by stimulation of endogenous NOD formation. Conclusion: Regulation of endogenous NOD formation towards 
normal physiological levels or hyperproduction of these compounds may result in tumor growth suppression.
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T�e role of nitric oxide in tumor biology is am-
biguous and is studied insufficiently. NO-production 
in �uman and animal organisms is based on enzymatic 
NO-synt�ase transformation of L-Arg-guanidine frag-
ment in t�e reaction wit� oxygen [�� �]. Long duration 
of NO-biosynt�esis ������� fold longer t�an basic level� 
results in genotoxicity effect� induces dose-dependant 
DNA-destruction etc� leading to tumor development. 
�ultifold increase in NO-production is considered 
to be a consequence of inducible NO-synt�ase acti-
vation �iNOS�� being expressed in different cell types 
in normal state and pat�ology� including macrop�ages� 
microglyal cells� keratinocytes� �epatocytes� astro-
cytes� endot�elial cells of blood vessels� epit�elial cells 
and a variety of �uman tumor cells affected by cyto-
kines: interleukin-� and �� interferon-γ or t�eir com-
bination wit� tumor necrosis factor-α or -β� etc [��7].
Direction of NO effect is defined by many factors: 
concentration� exposition� reaction products wit� key 
reagents �oxygen and its active forms� carbon dioxide� 
etc� and targets �metals� t�iol containing aminoacids� 
proteins� etc�. Clinical investigations s�ow t�at NOS 
expression in many tumor tissues is often disturbed. 
T�at is true for tumors of central nervous system� 
stomac�� colon and mammary gland� and melanoma� 
w�ere NOS activity is found to be elevated. A direct 
correlation is s�own between iNOS expression in tis-
sues of t�ese tumors and t�e following parameters: 
stage of a disease� vessel development in tumor� �ig� 
frequency of metastases� w�at result in poor prognosis 
[8���]. Animal experiments revealed t�at during iNOS 
activation� utilization of enzyme selective in�ibitors 
resulted in tumor growt� suppression [��� ��]. Exoge-
nous NO is s�own to in�ibit endogenous NO synt�esis. 
�ec�anisms of feedback include direct NOS inactiva-
tion via NO binding by �em-containing enzyme group 
and in�ibition of m-RNA iNOS expression [��].
At t�e same time NO plays a positive role in defense 
reactions of an organism. T�us� NO secreted by non-
specific immunity cells� macrop�ages and neutrop�ils� 
s�ows oxidizing and antimicrobial properties and is re-
sponsible for p�agocytes cytostatic and cytotoxic po-
tential wit� respect to tumor cells [�5]. T�ere is anot�er 
significant property of NO: apoptosis initiation� inclu-
ding t�at in transformed cells� due to violation of mi-
toc�ondrial oxidative p�osp�orylation� ribonucleotide 
reductase metabolism� etc [�6]. In some instances� 
w�en NO cell production is low �w�at promotes survival 
of transformed cells�� it is proposed t�at t�e activity 
of iNOS s�ould be restored wit� t�e use of medicinal 
agents or wit� gene t�erapy [7]. NO concentration 
in biological fluids of organism� tumor tissues� tumor 
microenvironment is s�own to predict t�e activity 
of key proteins for carcinogenesis — suc� as p5�� 
extracellular signal-regulated kinase �ERK�� �ypoxic 
inducible factor �HIF�� Akt etc. [�7]. Taking into account 
t�e above information a special scientific and practical 
interest will include investigations of NO biosynt�esis 
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levels upon t�e influence of NOS modulators and natu-
ral antioxidants in different models of tumor growt�.
T�e aim of t�e present study was to investigate t�e 
dynamics of nitric oxide derivatives �NOD� formation 
in mice wit� transplanted tumors and to analize w�et�-
er synt�etic NO-synt�ase in�ibitors� NO-donors and 
natural compounds could modulate NOD synt�esis.
MATERIALS AND METHODS
��� male F��C57BlxCBA�� CBA/Lac� BDF and 
Balb/c mice weig�ting ����� g were used in t�e work. 
Animals were fed wit� briquetted feed wit� constant 
access to water. All experimental procedures were con-
ducted following t�e normative rules of bioet�ics.E�rlic� 
carcinoma �EC� and Lewis lung carcinoma �LLC� tumor 
strains were received from Russian Oncologic Scientific 
Centre of RA�S ��oscow� Russia�. LLC and EC cells 
�5x��6 or ��6 cells per mice� were inoculated subcutane-
ously� in rig�t armpit and rig�t inguinal region.
T�e following reagents were used: Ng-monomet�yl-
L-arginine �L-N��A�� Nώ-nitro-L-arginine �L-NNA�� 
N-[[�-�aminomet�yl�p�enyl]met�yl]-et�animidamide 
di�ydroc�loride �����W�� aminoguanidine �AG� �Sig-
ma-RBI�; L-carnozine �CZ� �BioC�emika�. Ot�er re-
agents: nitroprusside �NP�� acetylsalicylic acid �ASA�� 
etc. were of Russian production. W�ile c�oosing NOS 
modulators� c�emical properties of compounds were 
taken into consideration [�].
Endogenous NOD formation in t�e organism 
was evaluated on two tumor growt� models — LLC 
�6� mice� and EC ��� mice� by analysis of nitrate �NA� 
and nitrite �NI� excretion wit� urine per day and t�eir 
concentration in tumor tissue. 
Gat�ering of diurnal urine for NA and NI analysis 
of mice F��C57BlxCBA� wit� LLC was ac�ieved before 
tumor transplantation and after it on t�e �d� �t�� �6t�� 
��st and ��t� day. NA and NI concentrations in tumor 
tissue were determined on t�e ��t�� ��st� �8t� and ��nd 
day of tumor growt�.
Gat�ering of diurnal urine of Balb/c-mice wit� 
EC was performed before EC transplantation and after 
it on t�e �t�� ��t�� �7t�� ��t� and ��nd day of tumor growt�. 
NA and NI concentrations in tumor tissue of BDF mice 
wit� EC transplanted tumor were determined on t�e 
��nd day of tumor growt�.
Investigation of synt�etic NOS in�ibitors and 
NO donors effect on EC growt� was carried out 
on ��� F��C57BlxCBA� and BDF mice. 7 groups of �y-
brid mice ����� animals per group� were formed. T�e 
control group was composed from �6 mice. BDF mice 
were divided into � groups� �� mice per group. EC was 
transplanted to all mice subcutaneously. T�e intra-
peritoneal introduction was used for administration 
of an active compound solution� �.� ml� 5 days per 
week �except special cases discussed later� to ani-
mals from t�e ��8t� groups beginning from t�e 8t� day 
after EC transplantation. In total� eac� animal received 
�� doses. T�ere were formed t�e following groups: 
�� control� �� treatment wit� 5� mg/kg L-N��A� �� 
��� mg/kg L-NNA� �� ��� mg/kg AG� 5� combined 
treatment wit� ��� mg/kg AG and �� mg/kg ASA. T�e 
6 group of animals received � mg/kg of NP on t�e �nd 
and �d day after EC transplantation and later sub-
cutaneously �� µg/kg of NP. T�e 7t� group received 
subcutaneously 8� µg/kg of NP on t�e 8t� day after 
EC transplantation. T�e 8t�-group of mice received 
���� mg/kg of CZ wit� water since t�e second day 
after transplantation and during all t�e experiment.
T�e effect of selective in�ibitor iNOS-����W 
on EC growt� was studied on �� BDF mice wit� trans-
planted EC �group �� control� n=��� and group ��� n=��� 
treated subcutaneously wit� �� mg/kg ����W in�ibitor 
solution from day � after tumor transplantation. In total� 
�� ����W administrations per animal were performed.
Investigation of effect of natural biologically ac-
tive compounds was analyzed in CBA/Lac �n=5��� 
F��C57BlxCBA� �n=5�� and Balb/c �n=��� male mice using 
t�e following preparations: pycnogenol �Pg�� containing 
>=6�% of procyanidins �Biolandes� France�� diquertin 
�Dq� wit�>��% of di�ydroquercetin �Flavir� Russia�� 
indol-�-carbinol �I-�-C� �Sigma�� p�enolic acids: gallic 
�GA�� tannic �TA� and also Se-enric�ed paprika �Se-P� 
� mg Se/kg �ayak cultivar grown on sodium selenate 
containing �.��% NPK-fertilizers� and algae spirulina- 
Arthospira platensis �Se-Sp� � g Se/kg; production of 
“Agro-Victoria” corporation� Russia�. T�e preparations 
were given per os as water suspensions ��� weeks 
before EC transplantation and after it up to t�e end of ex-
periment 5 times per week. T�e eut�anasia of animals 
was performed under t�e lig�t ester anest�etic.
Tumor growt� in�ibition �TGI� under t�e effect 
of tested compounds was estimated in tumor growt� 
dynamics using mass and volume parameters in com-
parison wit� t�e control group according to [�8].
For diural urine sampling animals were placed in ex-
c�ange cages �5 per cage� for �� � wit�out feeding 
and wit� free water access. To exclude NI oxidation 
�.� ml of ��% sodium �ydroxide solution was used. 
Removal of protein-carbo�ydrate component in urine 
water extract was ac�ieved using ZnS�� and potassium 
ferricyanide.
On t�e ��t�� ��st� �8t� days after LLC transplantation 
�or ��nd day for EC� t�e eut�anasia of animals under 
t�e lig�t ester anest�etic was performed. Tumors were 
removed� �omogenized and t�e samples of tissue ex-
tracts were obtained as follows: ��� g of �omogenized 
tumor tissue were placed in a calibrated vessel� bidis-
tilled water was added �tissue/water ratio= �:��� and 
t�e resulting mixture was �eated at 6�° С during �5 min. 
To prevent NI destruction� pH of water suspension was 
adjusted to 7.��7.� using buffer solution. T�en t�e 
mixure was cooled to room temperature� protein-car-
bo�ydrate component was removed by centrifugation 
for �5 min at 5�� g. NI and NA content in all reagents� 
water and materials was controlled.
NI and NA concentration in urine and tumors was 
determined by spectrop�otometric met�od using 
Griss reagent wit� prereduction of NA to NI by porous 
cadmium [��]. Optical density of colored solutions was 
determined on spectrop�otometer SF-�6. 
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Statistical analysis of t�e data �mean value±SD� 
was performed by standard met�ods using Stu-
dent’s t-test.
RESULTS AND DISCUSSION
EC growt� in Balb/c mice was accompanied 
by increase of NA and NI excretion wit� urine 
�Table ��. By t�e end of experiment �day ��� urine 
NI and NA excretion increased by �.6 �p<�.��� and 
67.� �p<�.��� times respectively compared to t�ese 
parameters of animals wit� t�e initial tumor nods �day 
��. NI excretion in EC-bearing mice was in t�e range 
�.6х���7—�.�х���6 mol/kg bw� and NA excretion — 
8.5х���8—5.7х���6 mol/kg bw. Total nitro compound 
excretion during EC growt� increased by �5.5 fold 
�in N��- equivalents�. During t�is period mean tumor 
volume increased by 67.� times. A positive correlation 
between EC volume and diurnal total NI and NA excre-
tion wit� urine was revealed �r=�.���.
NOD excretion by F��C57BlxCBA� mice wit� trans-
planted LLC demonstrated certain peculiarities 
�Table ��. One day after LLC inoculation maximal 
excretion values of NI and NA were �.� times �ig�er 
t�an t�e respective parameters of �ealt�y animals� and 
were constantly �ig�er by ��.��7�.5% versus control 
at all time points during LLC growt�.
NI concentration in LLC tumor tissue �Table �� 
was in t�e range of �.8��.6x���6 mol/kg� increasing 
monotonously during tumor development w�ereas 
NA concentration in t�e majority of samples was neg-
ligible. Total NA+NI content in tumor tissue did not 
exceed 5.�x���6 mol/kg and did not depend on tumor 
development.
Total amount of NI and NA in EC tumor tissue iso-
lated from BDF mice on day �� was 5.5 times �ig�er 
�p<�.��� t�an t�eir maximal total content in LLC tumor 
tissue �Table ��.
Investigation of t�e effect of synt�etic compounds 
capable to modulate NOS activity �as s�own t�at in-
traperitoneal administration of L-NNA ���� mg/kg�� AG 
���� mg/kg�� AG ���� mg/kg�+ASA ��� mg/kg�� to �y-
bride mice resulted in statistically significant EC growt� 
in�ibition �Table ��. T�e earliest and stable TGI was 
demonstrated for NNA ���%� p<�.���. AG caused 
low TGI ������%� p<�.�5� but in combination wit� 
ASA it in�ibited EC growt� more efficiently ������%� 
p<�.�5�. NP effect depended on t�e dose and rout 
of administration: subcutaneous administration 
Table 1. Urine NI and NA excretion in dynamics of Ehrlich carcinoma growth in Balb/c micea)
Parameter Day of tumor growth0 4 10 17 24 32
Tumor volume, mm3 No tumor 49±21 720±117 1480±197 2189±809 3300±462
N02- excretion 0 (3.6 ± 2.6)×10-7 (4.5 ± 1.09)×10-7 (5.8 ± 4.64)×10-7 (1.0 ± 0.53)×10-6 (1.3 ± 0.55)×10-6
N03- excretion 1.1 ± 0.44×10-7 (8.5 ± 9.9)×10-8 (8.9 ± 3.0)×10-7 (3.3 ± 1.1)×10-6 (3.1 ± 0.3)×10-6 (5.7 ± 2.97)×10-6
Total NI and NA excre-
tion (mol/kg bw)
(1.1 ± 0.44)×10-7 (4.45 ± 3.29)× 10-7 (1.34 ± 0.38)×10-6 (3.88 ± 1.41)×10-6 (4.1 ± 0.73)×10-6 (7.0 ± 3.63)×10-6
Note. a) mean values ± SD (n=10).
Table 2. Urine NI and NA excretion of F1(C57BlxCBA) mice bearing Lewis lung carcinoma 
Days of LLC growth / Group 
of animals
NI and NA excretiona), mol/kg bw Comparison with controlb)N02- N03- Total NI and NA
2 (2.94 ± 1.12) ×10-7 (3.42 ± 0.15)×10-6, p<0.01 (3.71 ± 0.20)×10-6, p<0.01 +91.2
9 0.0 (7.67 ± 2.31)×10-7, p<0.01 (7.67 ± 2.31)×10-7, p<0.01 -60.5
6 (5.93 ± 7.9)×10-8 (5.11 ± 4.0)×10-7, p<0.01 (5.7 ± 4.14)×10-7, p<0.01 -70.5
21 0.0 (1.18 ± 0.36)×10-6 (1.18 ± 0.36)×10-6 -39.2
30 0.0 (1.51 ± 0.43)×10-6 (1.51 ± 0.43)×10-6 -22.2
Control (healthy animals) (2.6 ± 1.04)×10-7 (1.68 ± 0.85)×10-6 (1.94 ± 1.12)×10-6 0.0
Note. a) mean values ± SD (n=10); compared to the control. b) (-) — % of NOD decrease; (+) — % of NOD increase.
Table 3. NI and NA concentration in tumor tissue of mice bearing LLC or EC
Mice (days of tumor growth)a) NI and NA concentration, mol/kg tissueN02- N03- Total NI and NA
F1 mice with LLC (14) (2.8 ± 1.1) ×10-6 0.0 (2.8 ± 1.1)×10-6
F1 mice with LLC (21) (3.70 ± 1.5)×10-6 (1.6 ± 0.6)×10-6 (5.3 ± 1.98)×10-6
F1 mice with LLC (28) (4.6 ± 1.5)×10-6 0.0 (4.6 ± 1.5)×10-6
BDF mice with EC (32) (1.19 ± 0.37)×10-6 (1.72 ± 0.38)×10-5 (2.91 ± 0.42)×10-5
Note. a) mean values + SD (for 10 animals).
Table 4. Effect of NO-synthase inhibitors on Ehrlich carcinoma growth and endogenous production of NOD derivatives in F1(C57BlxCBA) and BDF mice
Groups of EC-bea-
ring mice, compounds 
(dose, mg/kg bw)
Tumor growth inhibition 
(TGI), %*
NO2- excretion, 
mol/kg bw* NO3
- excretion, mol/kg bw* Total NI and NA, mol/kg bw (days of EC growth)
Effect on NOD 
excretion, %
1. Control 0 (0.68 ± 0.25)×10-6 (6.8 ± 2.24) × 10-6 (7.48 ± 2.57)×10-6 (22) 0
2. L-NMMA (50) 0 (1.5 ± 0.62)×10-6 p<0.01 (5.5 ± 1.59)×10-6 (7.0 ± 2.02)×10-6 (22) -6
3. L-NNA (100) 18–39 p<0.05; p<0.01 (0.79 ± 0.33)×10-6 (2.71 ± 1.03)×10-6 p<0.01 (3.50 ± 1.27)×10-6 p<0.01 (22) -53
4. AG (140) 18–22 p<0.05 (1.02 ± 0.36)×10-6 (4.53 ± 1.81)×10-6 p<0.05 (5.55 ± 2.19)×10-6 (22) -26
5. AG (140) + ASA (10) 20–42 p<0.05; p<0.01 ** **
6. EC + NP (4) +(28–124) p<0.05; p<0.01 (0.47 ± 0.15) × 10-6 (1.12 ± 0.33)×10-5 p<0.01 (1.17 ± 0.36)×10-5 p<0.01 (22) +56
7. NP (0.08) 21–26 p<0.05; p<0.01 ** **
8. CZ (130) 21–29 p<0.05; p<0.01 (1.78 ± 1.0)×10-6 (2.92 ± 1.17)×10-6 p<0.01 (4.70 ± 1.86)×10-6 p<0.05 (22) -37
9. Control 0 (0.35 ± 0.17)×10-6 (4.83 ± 2.12)×10-6 (5.18 ± 2.35)×10-6 (22) 0
10. 1400W (13.0) 0 (0.14 ± 0.13)×10-6 p<0.01 (3.74 ± 1.35)×10-6 (3.88 ± 1.49)×10-6 (22) -25
Note. *- compared with respective the control; +( )- increase in tumor growth; **-not determined; Ng-monomethyl-L-arginine (L-NMMA); Nώ-nitro-L-arginine (L-
NNA); AG — aminoguanidine; ASA — acetylsalicylic acid; NP — nitroprusside; CZ — L-carnozine. 1–8 groups — mice F1(C57BlxCBA). 9–10 groups — mice BDF.
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of 8� µg/kg of NP resulted in �6% EC growt� in�ibition 
�p<�.�5� but intraperitoneal administration of �ig�er 
dose �� mg/kg� on days � and � after EC transplanta-
tion stimulated tumor growt� up to ���% �p<�.���. 
In mice treated wit� L-NNA and AG tumor growt� 
in�ibition by 5�% �p<�.��� and a decrease of NOD 
formation by �6% were recorded.
It s�ould be pointed out t�at L-N��A often used 
in investigations as iNOS in�ibitor �5� mg/kg� did not 
affect EC growt� w�ile N�D excretion wit� urine was 
close to t�at of control animals. Subcutaneous admin-
istration of ����W� selective iNOS in�ibitor ��� mg/kg�� 
did not cause statistically significant EC tumor depres-
sion t�oug� NOD excretion was decreased by �5.�%.
Investigation of natural preparation effect 
on EC growt� �as s�own t�at prolonged per os con-
sumption of �5� mg PG/kg and 75 mg I-�-C/kg caused 
statistically significant TGI by 5�% and 56% respec-
tively �p<�.���. During t�e w�ole experiment Pg effect 
was stable and resulted in ��% decrease of tumor 
mass �p<�.���. GA ���� mg/kg�� TA ���� mg/kg� and 
Se-Sp �� g/kg� statistically significantly increased t�e 
latent period of tumor nod formation by �.���.6 times 
and in�ibited tumor growt� during two weeks after 
EC transplantation. At t�e early stages of EC develop-
ment TGI was equal to ��% �GA�� 78% �TA�� 75% �Sp�� 
8�% �Se-Sp� and 65% �Se-P� �p<�.�5�.
Total NI and NA excretion detected on days ��� 
�� or �� of EC growt� in control group of animals was 
6.�x���6 mol/kg bw �F� mice�; �.��x���5 mol/kg bw 
�CBA/Lac mice� and 6.��x���6 mol/kg bw �Balb/c mice� 
�Table 5�. Pg� Dq� TA� Sp and Se-P administration 
resulted in increase of NOD excretion by ��.�% 
�p<�.�5�� �7.�% �p<�.�5�� �7.7%� 65.6% �p<�.��� 
and ���.6% �p<�.��� accordingly compared to t�e 
control group of animals. Only GA in�ibited NO forma-
tion by ��% �p<�.�5� on day �� of EC growt� w�ereas 
I-�-C and Se-Sp did not affect NO biosynt�esis.
T�us� t�e results �ave s�own t�at EC growt� is ac-
companied by increased NOD formation w�ereas LLC 
tumor growt� is c�aracterized by depression of NOD 
biosynt�esis. It s�ould be noted t�at NO endogenous 
synt�esis determination via NOD urine excretion is an in-
tegral parameter including also t�e amount of NOD� be-
ing formed from nitrogen oxide� necessary for normal 
function of cardiovascular� immune� endocrine and ner-
vous systems. NO synt�esis by constitutive NO-synt�ase 
isoforms is considered not to be accompanied by toxic 
effects of NO and its derivatives as concentration levels 
capable to cause necessary p�ysiological reactions are 
in nano-to micromolar range [��]. T�ere are few data 
on NO levels in animal tumor tissues. Study of �uman 
breast cancer �CF7 cells �as s�own t�at t�e activity 
of several key proteins �HIF-�α� ERK� and p5� � is regu-
lated by distinct t�res�old concentrations of nitric oxide. 
At low steady-state concentrations of NO �<5� nmol�� 
ERK p�osp�orylation was induced via a guanylate 
cyclase-dependent mec�anism. HIF-�α accumulation 
was associated wit� an intermediate amount of NO 
�>�.�x���7 ��� w�ereas p5� serine �5 p�osp�orylation 
occurred at considerably �ig�er levels �>�.�x���7 �� [�7].
In our experiment endogenous formation of NOD 
in EC mice beginning from t�e �t� to t�e ��t� day of tumor 
growt� was in t�e range �.�x���7�7.�x���6 mol/kg bw and 
for LLC-mice — 5.7x���7��.7�x���6 mol/kg bw. At t�e 
same time t�e total NI and NA concentration in tumor 
tissue was �.��x���5 mol/kg� w�ile NOD concentration 
in LLC tumor did not exceed 5.�x���6 mol/kg tissue. 
It is obvious t�at mean NOD concentration in EC and 
LLC tumors is significantly �ig�er t�an concentrations 
necessary for activation of proteins responsible for cells 
proliferation and apoptosis.
One can assume t�at t�e ability of NOS in�ibitors 
�L-NNA and AG� to suppress tumor growt� is related 
to t�eir ability to depress iNOS activity [��]. Also it �as 
been s�own t�at NP could �ave oppositely directed 
effects and stimulate tumor growt� at t�e relatively 
�ig� doses �� mg/kg� and suppress it at lower doses 
�8� µg/kg�. T�ere are t�e data demonstrating t�at 
in tumor microenvironment wit� low content of glucose 
and oxygen tumor cells may be more sensitive to �ig� 
concentrations of NO and peroxinitrite t�at normal 
ones. T�at is w�y in several cases NO donors are con-
sidered to be effective for promotion of c�emo- and 
radiot�erapy efficiency [�6]. However� we �ave s�own 
t�at EC �as been developing against t�e augmented 
NOD biosynt�esis and double intra-peritoneal injection 
of a �ig� NP dosage t�e next day after EC inoculation� 
w�ic� only stimulated tumor growt�.
Table 5. Effect of natural antioxidants on Erlich carcinoma growth and endogenous production of NO derivatives (NOD) in CBA/Lac, F1(C57BlхСВА) and Balb/c mice
Groups EC mice, 
compounds (dose, 
mg/kg bw)
Parameters
Tumor growth inhibition 
(TGI), or increase in tu-
mor growth (+), %*
NO2- excretion, 
mol/kg bw* NO3
- excretion, mol/kg bw* Total NI and NA mol/kg bw, (days of EC growth)
Effect on NOD 
excretion, %
CBA/Lac (control) 0 (2.3 ± 0.9)×10-6 (0.88 ± 0.24)×10-5 (1.11 ± 0.30)×10-5 (21) 0
CBA/Lac Pg (150) 31–52 p<0.01 (3.2 ± 1.1)×10-6 (1.28 ± 0.56)×10-5 p<0.05 (1.6 ± 0.67)×10-5 p<0.05 (21) +44.2
CBA/Lac VS (300) ( + ) 45 p<0.05 (2.1 ± 0.8)×10-6 (1.06 ± 0.32)×10-5 (1.27 ± 0.38)×10-5 (21) +14.4
CBA/Lac Dq (150) 0 (3.2 ± 1.2)×10-6 (1.32 ± 0.51)×10-5 p<0.05 (1.64 ± 0.61)×10-5 p<0.05 (21) +47.8
CBA/Lac I-C (75) 27–56 p<0.01 (2.3 ± 0.9)×10-6 (0.92 ± 0.33)×10-5 (1.15 ± 0.42)×10-5 (21) +3.6
F1 (control) 0 (0.94 ± 0.38)×10-6 (5.46 ± 1.69)×10-6 (6.4 ± 1,9)×10-6 (14) 0
F1 GA (100) 27–91 p<0.05; p<0.01 (1.02 ± 0.44)×10-6 (3.33 ± 1.17)×10-6 p<0.01 (4.35 ± 1.48)×10-6 p<0.05 (14) -32.0
F1 TA (100) 24–78 p<0.01 (1.34 ± 0.50)×10-6 (6.83 ± 2.73)×10-6 (8.17 ± 3.04)×10-6 (14) +27.7
F1 Sp (1000) 41–75 p<0.05; p<0.01 (1.5 ± 0.5)×10-6 p<0.05 (0.91 ± 0.25)×10-5 p<0.01 (1.06 ± 0.28)×10-5 p<0.01 (14) +65.6
F1 Se-Sp (1000) 41–89 p<0.05; p<0.01 (1.42 ± 0.58)×10-6 (4.43 ± 1.9) ×10-6 (5.85 ± 2.35) × 10-6 (14) -8.6
Balb/c (control) 0 (0.87 ± 0.30)×10-6 (5.42 ± 1.52)×10-6 (6.29 ± 1.73)×10-6 (23) 0
Balb/c Se-P (1000) 38–65 p<0.05; p<0.01 (0.9 ± 0.4)×10-6 (1.26 ± 0.54)×10-5 p<0.01 (1.35 ± 0.57)×10-5 p<0.01 (23) +114.6
Note: Each group contained 10 mice. Natural antioxidants: pycnogenol (Pg), diquertin (Dq), indol-carbinol (I-C), phenolic acids: gallic acid (GA) and tannic 
acid (TA), vine stone (VS) and Se-enriches plants: sweet pepper (Se-P), spirulina (Se-Sp); * — compared with respective control.
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Lack of L-N��A-dependent in�ibition of NOD 
endogenous formation can be explained by peculiari-
ties of its metabolism. It is known t�at NOS converts 
L-N��A to N-�ydroxy-N-met�yl-L-agrinine� w�ic� 
in�ibits t�e enzyme irreversibly. But in certain tissues 
and cells especially in �ypoxic conditions� L-N��A 
metabolism may be accompanied by t�e formation 
of L-arginine or may possess ot�er peculiarities [�].
Taking into account t�e NOD endogenous forma-
tion in a model of EC tumor growt�� its �5�5�% reduc-
tion upoin t�e use of L-NNA� AG and ���W appears 
to be insufficient to attain its normal p�ysiological level. 
In conditions of developing tumor acceptable iNOS 
blocking will not be able to produce stable defense 
response of an organism� but may retard tumor growt�. 
At t�e same time significant depression of iNOS activity 
may �ave also negative consequences. It is known t�at 
N� is formed in t�e oxidation reaction of L-arginine� 
w�ic� is also a precursor of endogenous synt�esis 
of polyamines. T�is supposes t�e existence of an inte-
grated mec�anism of nitric oxide and polyamine syn-
t�esis regulation. Polyamines are known to stimulate 
mammalian cells proliferation and potentiate carcino-
genesis. T�e results s�ow t�at blocking of NO-synt�ase 
may cause pretumor c�anges in intestine due to t�e 
decreased NO release and induction of ornitine-de-
carboxylase — an enzyme of polyamine synt�esis [��].
A study of t�e effect of natural compounds wit� 
pronounced antioxidant properties on tumor growt� 
and endogenous NOD formation �as revealed t�at 
t�e use of � from � tested compounds resulted in tu-
mor suppression on t�e background of stimulation 
of NOD formation. One can suppose t�at suc� effect 
could be related not only to direct reactions wit� free 
radicals so typical for antioxidants but also to ot�er 
mec�anisms involved in stimulation of detoxification 
defense systems t�roug� antioxidant responsive 
elements present in t�e promoter region of genes 
inducible upon oxidative and c�emical stresses [��].
In conclusion� our study �as demonstrated t�at 
EC development is accompanied by increased endo-
genous NOD formation w�ile LLC growt� — by depres-
sion of NOD synt�esis. �odulators of NO-synt�ase 
activity �L-NNA and AG� decreased NOD formation� 
inducing simultaneously moderate� but stable de-
crease of tumor development in EC-bearing mice. T�e 
use of NP �ad oppositely directed effects on EC growt� 
dependent on t�e dose and t�e rout of administration. 
�ost of natural antioxidants tested demonstrated 
antitumor activity at t�e early stage of EC growt� 
stimulating endogenous NOD formation.
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